{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Palm Harbor",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89808",
      "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy",
      "address_1": "34911 Us Highway 19 N Ste 600",
      "address_2": "N/A",
      "postal_code": "34684-1921",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA including Puerto Rico.",
      "recall_number": "D-0731-2022",
      "product_description": "TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar",
      "product_quantity": "73 vials",
      "reason_for_recall": "Lack of sterility assurance.",
      "recall_initiation_date": "20220323",
      "center_classification_date": "20220329",
      "termination_date": "20231005",
      "report_date": "20220406",
      "code_info": "Lots: a)750851 BUD: 7/18/2022; b) 754549 BUD: 8/2/2022"
    }
  ]
}